comparemela.com

Latest Breaking News On - Sylvie berrebi frazer hall - Page 2 : comparemela.com

Investegate |Oxurion NV Announcements | Oxurion NV: Oxurion Receives Transparency Notifications from Fidelity Management & Research Company LLC and Novartis Pharma AG

Investegate announcements from Oxurion NV, Oxurion Receives Transparency Notifications from Fidelity Management & Research Company LLC and Novartis Pharma AG

United statesRegion flamandeTom graneySylvie berrebi frazer hallChristopher brinzeyFidelity management research companyCompany or oxurionOxurion receives transparency notificationsFidelity managementResearch companyNovartis pharmaEuronext brusselsNovartis notificationInvestegate announcementsInvestegate company announcementsOxurion nv

Oxurion NV: Oxurion Receives Transparency Notifications from Fidelity Management & Research Company LLC and Novartis Pharma AG

Leuven, Belgium, Boston, MA, US - March 17, 2022 - 07.00 PM CET - Oxurion NV(Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation

United statesRegion flamandeTom graneySylvie berrebi frazer hallChristopher brinzeyFidelity management research companyCompany or oxurionEuronext brusselsFidelity managementResearch companyNovartis pharmaNovartis notificationTransparency notification

Oxurion NV: Oxurion Successfully Closes EUR >10 Million in Private Placement

Led by new top-tier healthcare institutional investors along with participation by current major shareholders Leuven, BELGIUM, Boston, MA, US - MARCH 7, 2022 - 10.00 AM CET - Oxurion

United statesRegion flamandeTom graneySylvie berrebi frazer hallChristopher brinzeyCompany annualCompany or oxurionEuronext brusselsPrivate placement

Investegate |Oxurion NV Announcements | Oxurion NV: OXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US AND EUROPEAN HEALTHCARE INVESTORS IN A PRIVATE EQUITY PLACEMENT

Investegate announcements from Oxurion NV, OXURION SUCCESSFULLY RAISES EUR

United statesRegion flamandeUnited kingdomTom graneyBaron philippe vlerickSylvie berrebi frazer hallThomas clayChristopher brinzeyBelgian code on companiesCouncil of the european unionCompany annualEuropean parliamentBank degroof petercam sa nv degroofpetercamFinancial servicesSwiss financial services act finanzdienstleistungsgesetzBelfius bank

Oxurion NV: OXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US AND EUROPEAN HEALTHCARE INVESTORS IN A PRIVATE EQUITY PLACEMENT

Leuven, BELGIUM, Boston, MA, US - MARCH 3, 2022 - 08:00 AM CET - Oxurion NV (Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation

United statesRegion flamandeUnited kingdomTom graneyBaron philippe vlerickSylvie berrebi frazer hallThomas clayChristopher brinzeyBelgian code on companiesCouncil of the european unionCompany annualEuropean parliamentBank degroof petercam sa nv degroofpetercamFinancial servicesSwiss financial services act finanzdienstleistungsgesetzBelfius bank

vimarsana © 2020. All Rights Reserved.